Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial Cells
Schizophrenia is a complex psychiatric disorder that exhibits an interconnection between the immune system and the brain. Experimental and clinical studies have suggested the presence of neuroinflammation in schizophrenia. In the present study, the effect of antipsychotic drugs, including clozapine,...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/3/577 |
id |
doaj-cc15d74bef944025b2b4db7c4cdc28f5 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Vijayasree V. Giridharan Giselli Scaini Gabriela D. Colpo Tejaswini Doifode Omar F. Pinjari Antônio L. Teixeira Fabricia Petronilho Danielle Macêdo João Quevedo Tatiana Barichello |
spellingShingle |
Vijayasree V. Giridharan Giselli Scaini Gabriela D. Colpo Tejaswini Doifode Omar F. Pinjari Antônio L. Teixeira Fabricia Petronilho Danielle Macêdo João Quevedo Tatiana Barichello Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial Cells Cells microglia poly (i:c) inflammation nlrp3 cytokines schizophrenia |
author_facet |
Vijayasree V. Giridharan Giselli Scaini Gabriela D. Colpo Tejaswini Doifode Omar F. Pinjari Antônio L. Teixeira Fabricia Petronilho Danielle Macêdo João Quevedo Tatiana Barichello |
author_sort |
Vijayasree V. Giridharan |
title |
Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial Cells |
title_short |
Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial Cells |
title_full |
Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial Cells |
title_fullStr |
Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial Cells |
title_full_unstemmed |
Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial Cells |
title_sort |
clozapine prevents poly (i:c) induced inflammation by modulating nlrp3 pathway in microglial cells |
publisher |
MDPI AG |
series |
Cells |
issn |
2073-4409 |
publishDate |
2020-02-01 |
description |
Schizophrenia is a complex psychiatric disorder that exhibits an interconnection between the immune system and the brain. Experimental and clinical studies have suggested the presence of neuroinflammation in schizophrenia. In the present study, the effect of antipsychotic drugs, including clozapine, risperidone, and haloperidol (10, 20 and 20 μM, respectively), on the production of IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-17, IL-18, INF-γ, and TNF-α was investigated in the unstimulated and polyriboinosinic-polyribocytidilic acid [poly (I:C)]-stimulated primary microglial cell cultures. In the unstimulated cultures, clozapine, risperidone, and haloperidol did not influence the cytokine levels. Nevertheless, in cell cultures under strong inflammatory activation by poly (I:C), clozapine reduced the levels of IL-1α, IL-1β, IL-2, and IL-17. Risperidone and haloperidol both reduced the levels of IL-1α, IL-1β, IL-2, and IL-17, and increased the levels of IL-6, IL-10, INF-γ, and TNF-α. Based on the results that were obtained with the antipsychotic drugs and observing that clozapine presented with a more significant anti-inflammatory effect, clozapine was selected for the subsequent experiments. We compared the profile of cytokine suppression obtained with the use of NLRP3 inflammasome inhibitor, CRID3 to that obtained with clozapine, to test our hypothesis that clozapine inhibits the NLRP3 inflammasome. Clozapine and CRID3 both reduced the IL-1α, IL-1β, IL-2, and IL-17 levels. Clozapine reduced the level of poly (I:C)-activated NLRP3 expression by 57%, which was higher than the reduction thay was seen with CRID3 treatment (45%). These results suggest that clozapine might exhibit anti-inflammatory effects by inhibiting NLRP3 inflammasome and this activity is not typical with the use of other antipsychotic drugs under the conditions of strong microglial activation. |
topic |
microglia poly (i:c) inflammation nlrp3 cytokines schizophrenia |
url |
https://www.mdpi.com/2073-4409/9/3/577 |
work_keys_str_mv |
AT vijayasreevgiridharan clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells AT giselliscaini clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells AT gabrieladcolpo clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells AT tejaswinidoifode clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells AT omarfpinjari clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells AT antoniolteixeira clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells AT fabriciapetronilho clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells AT daniellemacedo clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells AT joaoquevedo clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells AT tatianabarichello clozapinepreventspolyicinducedinflammationbymodulatingnlrp3pathwayinmicroglialcells |
_version_ |
1725322323205029888 |
spelling |
doaj-cc15d74bef944025b2b4db7c4cdc28f52020-11-25T00:31:47ZengMDPI AGCells2073-44092020-02-019357710.3390/cells9030577cells9030577Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial CellsVijayasree V. Giridharan0Giselli Scaini1Gabriela D. Colpo2Tejaswini Doifode3Omar F. Pinjari4Antônio L. Teixeira5Fabricia Petronilho6Danielle Macêdo7João Quevedo8Tatiana Barichello9Translational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054 USATranslational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054 USATranslational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054 USATranslational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054 USATranslational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054 USATranslational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054 USALaboratory of Neurobiology of Inflammatory and Metabolic Processes, Graduate Program in Health Sciences, Health Sciences Unit, University of South Santa Catarina, Tubarão, 88700-000 Santa Catarina, BrazilNeuropsychopharmacology Laboratory, Drug Research, and Development Center, Faculty of Medicine, Universidade Federal do Ceará, 60020-181 Fortaleza CE, Brazil; National Institute for Translational Medicine (INCT-TM, CNPq), 14000-000 Ribeirão Preto, SP, BrazilTranslational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054 USATranslational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX 77054 USASchizophrenia is a complex psychiatric disorder that exhibits an interconnection between the immune system and the brain. Experimental and clinical studies have suggested the presence of neuroinflammation in schizophrenia. In the present study, the effect of antipsychotic drugs, including clozapine, risperidone, and haloperidol (10, 20 and 20 μM, respectively), on the production of IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-17, IL-18, INF-γ, and TNF-α was investigated in the unstimulated and polyriboinosinic-polyribocytidilic acid [poly (I:C)]-stimulated primary microglial cell cultures. In the unstimulated cultures, clozapine, risperidone, and haloperidol did not influence the cytokine levels. Nevertheless, in cell cultures under strong inflammatory activation by poly (I:C), clozapine reduced the levels of IL-1α, IL-1β, IL-2, and IL-17. Risperidone and haloperidol both reduced the levels of IL-1α, IL-1β, IL-2, and IL-17, and increased the levels of IL-6, IL-10, INF-γ, and TNF-α. Based on the results that were obtained with the antipsychotic drugs and observing that clozapine presented with a more significant anti-inflammatory effect, clozapine was selected for the subsequent experiments. We compared the profile of cytokine suppression obtained with the use of NLRP3 inflammasome inhibitor, CRID3 to that obtained with clozapine, to test our hypothesis that clozapine inhibits the NLRP3 inflammasome. Clozapine and CRID3 both reduced the IL-1α, IL-1β, IL-2, and IL-17 levels. Clozapine reduced the level of poly (I:C)-activated NLRP3 expression by 57%, which was higher than the reduction thay was seen with CRID3 treatment (45%). These results suggest that clozapine might exhibit anti-inflammatory effects by inhibiting NLRP3 inflammasome and this activity is not typical with the use of other antipsychotic drugs under the conditions of strong microglial activation.https://www.mdpi.com/2073-4409/9/3/577microgliapoly (i:c)inflammationnlrp3cytokinesschizophrenia |